Business · 10/12/1998Updated: 10/17/2026 · 1 min read
FDA Announces 1999 Oversight Committee Meetings for Product, Establishment, and Biologics License Applications
Summary
The Food and Drug Administration (FDA) is conducting a review of its refusal to file (RTF) practices on product license applications (PLA's), establishment license applications (ELA's), and biologics license applications (BLA's) and will assess consistency across its offices and divisions in RTF decisions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →